Spironolactone responsive familial hypertension. a potentially high prevalence of mineralocorticoid disease in Oman
Woodhouse, N.J.; Elshafie, O.T.; Mehar, A.; Johnston, W.J.; Al-Kaabi, J.M.
Saudi Medical Journal 24(2): 229-231
2003
ISSN/ISBN: 0379-5284 PMID: 12682699 Document Number: 555710
Document emailed within 1 workday
Related Documents
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071Cutler, G.B.; Sauer, M.A.; Loriaux, D.L. 1979: SC 25152: a potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone Journal of Pharmacology and Experimental Therapeutics 209(1): 144-146
Pisani, M. 1994: L'Ambasciata di Francia nel Sultanato dell'Oman - The French embassy in the Oman Sultanate - L'Ambassade de France dans le Sultanat d'Oman Industria Delle Costruzioni 28(269): 16-19
Carmichael, A.J.; Tan, C.Y.; Smith, A.G. 1989: Familial sarcoidosis: high ethnic prevalence Acta Dermato-Venereologica 69(6): 531-532
Ahmed, T.; Ciavarella, D.; Feldman, E.; Ascensao, J.; Hussain, F.; Engelking, C.; Gingrich, S.; Mittelman, A.; Coleman, M.; Arlin, Z.A. 1989: High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease Leukemia 3(1): 19-22
Al Riyami, A.; Elaty, M.A.A.; Morsi, M.; Al Kharusi, H.; Al Shukaily, W.; Jaju, S. 2012: Oman world health survey: part 1 - methodology, sociodemographic profile and epidemiology of non-communicable diseases in oman Oman Medical Journal 27(5): 425-443
Janiak, P.C.; Lewis, S.J.; Brody, M.J. 1990: Role of central mineralocorticoid binding sites in development of hypertension American Journal of Physiology 259(5 Pt 2): R1025-R1034
Miss-Pages, C.; Gairard, A. 1975: Relationship between the level of mineralocorticoid arterial hypertension and calcium metabolism in the rat Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 169(3): 700-705
Marchetti, J.; Thibonnier, M.; Gonzales, M.F.; Corvol, P.; Menard, J. 1980: Dynamic study of antidiuretic hormone during benign mineralocorticoid and metacorticoid hypertension Acta Endocrinologica 95(4): 444-453
Jawad, L.A.; Al-Mamry, J.M.; Al-Mamary, D.S.; Al-Rasady, E.H. 2013: First record of the slender ponyfish, Equulites elongatus Gunther, 1874 Family Leiognathidae from the coasts of Muscat City at the Sea of Oman, Sultanate of Oman Journal of Applied Ichthyology 29(2): 456-459
Kanatu, K. 1977: Clinical studies of hypertension in patients undergoing regular maintenance hemodialysis. 1) a comparison of hemodynamic data and plasma renin activity between responsive and resistant hypertension to regular dialysis alone. 2) Beta adrenergic blockade in resistant hypertension Nihon Jinzo Gakkai Shi 19(11): 871-881
Akbar, F.A.; Boston, P.F.; Chapman, J.; Pearce, M.Y. 1981: Spironolactone and hydroflumethiazide in the treatment of hypertension British Journal of Clinical Practice 35(9): 317-321
Kornhauser, C.; Malacara, J.M.; Donato, F.; Botello, D. 1994: High prevalence of arterial hypertension in women over 50 years of age in the city of Leon, Guanajuato Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 46(4): 287-294
Antonov, A.R.; Efremov, A.V.; Markel', A.L.; Petrova, G.V.; Iakobson, M.G.; Iakobson, G.S. 2000: Changes in gluco- and mineralocorticoid adrenal functions in rats with inherited arterial hypertension during experimental myocardial infarction Biulleten' Eksperimental'noi Biologii i Meditsiny 129(1): 25-27
Al Madhani, A.; Al Harthi, L.; Balkhair, A.; Chan, M.F.; Albusaidi, B.S.; Al Sibani, N.; Al-Adawi, S. 2020: Prevalence and correlates of depressive symptoms among people living with HIV attending tertiary care hospitals in Oman Pan African Medical Journal 37: 90
Faris, M.; Al-Bahrani, B.; Emam Khalifa, A.; Ahmad, N. 2007: Evaluation of the prevalence, pattern and management of cancer pain in Oncology Department, The Royal Hospital, Oman Gulf Journal of Oncology 1(1): 23-28
Di Veroli, C.; Compagno, S.; Iugoli, A.R. 1982: Spironolactone and propranolol in combination therapy of arterial hypertension La Clinica Terapeutica 103(3): 283-287
Kreeft, J.H.; Larochelle, P.; Ogilvie, R.I. 1983: Comparison of chlorthalidone and spironolactone in low--renin essential hypertension Canadian Medical Association Journal 128(1): 31-34
Fagerberg, S.E.; Göransson, K. 1974: A comparative study of spironolactone and chlorthalidone in treatment of hypertension Lakartidningen 71(3): 175-177
Jamil, M.A. 1971: A comparative study of spironolactone and hydroflumethiazide alone and together in the treatment of hypertension Guy's Hospital Reports 120(3): 207-219